Trial Outcomes & Findings for Memory and Attention Adaptation Training-Geriatrics (MAAT-G) (NCT NCT04230941)

NCT ID: NCT04230941

Last Updated: 2023-11-13

Results Overview

The System Usability Scale is a metric to evaluate the usability of the intervention (Patients) and is scored 0 (minimum) to 100 (maximum). Higher scores indicate greater usability. A mean score \>68 is consisted with optimal usability.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

Post-Intervention (up to 2 weeks)

Results posted on

2023-11-13

Participant Flow

Participant milestones

Participant milestones
Measure
MAAT-G Intervention
MAAT-G Workshops \& participant workbook use (10 workshops) MAAT-G: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) is a cognitive-behavioral therapy (CBT)-based intervention for Cancer Related Cognitive Decline (CRCD). As a CBT-based intervention, MAAT-G focuses on an individual's psychological response to injury as compared to the biological events triggering CRCD. MAAT-G is a series of manualized workshops delivered by a psychologist via video-conferencing, supplemented by a participant workbook, which provide instruction and practice with adaptive behavioral coping skills, stress management techniques, and compensation strategies. MAAT-G has been adapted to optimize usability. We are evaluating the usability of MAAT-G.
Caregiver
Optional for caregiver to enroll with patient. Caregivers were not required to enroll for patients to be able to participate.
Overall Study
STARTED
4
1
Overall Study
COMPLETED
4
1
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Memory and Attention Adaptation Training-Geriatrics (MAAT-G)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
MAAT-G Intervention
n=4 Participants
MAAT-G Workshops \& participant workbook use (10 workshops) MAAT-G: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) is a cognitive-behavioral therapy (CBT)-based intervention for CRCD. As a CBT-based intervention, MAAT-G focuses on an individual's psychological response to injury as compared to the biological events triggering CRCD. MAAT-G is a series of manualized workshops delivered by a psychologist via video-conferencing, supplemented by a participant workbook, which provide instruction and practice with adaptive behavioral coping skills, stress management techniques, and compensation strategies. MAAT-G has been adapted to optimize usability. We are evaluating the usability of MAAT-G.
Caregiver
n=1 Participants
Caregivers were optional to enroll with patients. A caregiver was not required to enroll for a patient to participate.
Total
n=5 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
4 Participants
n=5 Participants
1 Participants
n=7 Participants
5 Participants
n=5 Participants
Age, Continuous
73.25 years
n=5 Participants
78 years
n=7 Participants
73.8 years
n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
0 Participants
n=7 Participants
4 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
1 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
4 Participants
n=5 Participants
1 Participants
n=7 Participants
5 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Post-Intervention (up to 2 weeks)

The System Usability Scale is a metric to evaluate the usability of the intervention (Patients) and is scored 0 (minimum) to 100 (maximum). Higher scores indicate greater usability. A mean score \>68 is consisted with optimal usability.

Outcome measures

Outcome measures
Measure
MAAT-G Intervention
n=4 Participants
MAAT-G Workshops \& participant workbook use (10 workshops) MAAT-G: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) is a cognitive-behavioral therapy (CBT)-based intervention for CRCD. As a CBT-based intervention, MAAT-G focuses on an individual's psychological response to injury as compared to the biological events triggering CRCD. MAAT-G is a series of manualized workshops delivered by a psychologist via video-conferencing, supplemented by a participant workbook, which provide instruction and practice with adaptive behavioral coping skills, stress management techniques, and compensation strategies. MAAT-G has been adapted to optimize usability. We are evaluating the usability of MAAT-G.
Caregiver
Optional for caregiver to enroll with patient. Caregivers were not required to enroll for patients to be able to participate.
System Usability Scale (SUS)
90.6 score on a scale
Interval 67.5 to 100.0

PRIMARY outcome

Timeframe: Post-Intervention (up to 2 weeks)

Population: MAX QDA Software utilized for qualitative analysis coding

Semi-structured interview with patients and caregivers about experience with MAAT-G. (Patients and caregivers) Qualitative Analysis of transcripts from participant/caregiver interviews will be analyzed for themes on intervention benefit and barriers and facilitators.

Outcome measures

Outcome measures
Measure
MAAT-G Intervention
n=4 Participants
MAAT-G Workshops \& participant workbook use (10 workshops) MAAT-G: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) is a cognitive-behavioral therapy (CBT)-based intervention for CRCD. As a CBT-based intervention, MAAT-G focuses on an individual's psychological response to injury as compared to the biological events triggering CRCD. MAAT-G is a series of manualized workshops delivered by a psychologist via video-conferencing, supplemented by a participant workbook, which provide instruction and practice with adaptive behavioral coping skills, stress management techniques, and compensation strategies. MAAT-G has been adapted to optimize usability. We are evaluating the usability of MAAT-G.
Caregiver
n=1 Participants
Optional for caregiver to enroll with patient. Caregivers were not required to enroll for patients to be able to participate.
Experience Interview
Number of participants describing the MAAT-G intervention as beneficial
4 Participants
1 Participants
Experience Interview
Number of participants using study-based facilitators to overcome Telehealth barriers
3 Participants
1 Participants

Adverse Events

MAAT-G Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Caregiver

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Allison Magnuson, (Principal Investigator), Associate Professor of Medicine

University of Rochester

Phone: 585-276-7155

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place